Official UK procurement notice
NP37719 Sevoflurane & Isoflurane
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)
What is being bought3 lots · detail below
Published requirement descriptionSupply of Sevoflurane & Isoflurane to NHS Scotland.
CPV: Pharmaceutical products
Lots and requirements (3)Procurement structure
3 lots · no lot values publishedLot #1Sevoflurane, including loan of vaporisers
The Framework Agreement is for the supply of Sevoflurane, including loan of vaporisers to NHS Scotland. The Framework Agreement has been awarded as a ranked multi supplier framework agreement.
The Framework Participant is required to supply Goods to designated delivery points throughout Scotland for use by Participating Authorities.
Lot #2Sevoflurane, bottle only
The Framework Agreement is for the supply of Sevoflurane, bottle only to NHS Scotland. The Framework Agreement has been awarded as an Unranked Multi supplier framework agreement.
The Framework Participant is required to supply Goods to designated delivery points throughout Scotland for use by Participating Authorities.
Lot #3Isoflurane, bottle only
The Framework Agreement is for the supply of Isoflurane, bottle only to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement.
The Framework Participant is required to supply Goods to designated delivery points throughout Scotland for use by Participating Authorities.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 12 Dec 2023, 09:09 GMT
- Last source update
- 12 Dec 2023, 09:09 GMT
- FTS notice number
2023/S 000-036451- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0424c5Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This VEAT Notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.
- Review procedure
The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication
method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority
proposes to conclude the relevant framework agreement.
The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering
into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings
to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include
the setting aside of the decision to award the framework agreement to the winning tenderer.
The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework
agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be
established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited
to the award of damages.
Publisher note: The estimated value of the Framework Agreement referred to in Section 11.1.7 cover(s) the 48 month contract duration of the Framework Agreement. The estimated value in Section V.2.4 covers the additional 12 month extension period of the Framework Agreement. NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=752162. (SC Ref:752162)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast3 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Sevoflurane, bottle only
- Signed
- 1 Dec 2023
- Value
- £23,649
- Status
- active
Sevoflurane, including loan of vaporisers
- Signed
- 1 Dec 2023
- Value
- £958,008
- Status
- active
Isoflurane, bottle only
- Signed
- 1 Dec 2023
- Value
- £8,346
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court House EdinburgReview body
Framework contractors & participating bidders
3 commercial parties on the notice- AbbVie LtdFramework contractor
- Baxter Healthcare LtdFramework contractor
- Piramal Critical CareFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.